Literature DB >> 20605351

Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.

Dirk Rades1, Sarah Douglas, Stefan Huttenlocher, Volker Rudat, Theo Veninga, Lukas J A Stalpers, Hiba Basic, Johann H Karstens, Peter J Hoskin, Irenaeus A Adamietz, Steven E Schild.   

Abstract

PURPOSE: A score predicting post-radiotherapy (RT) ambulatory status was developed based on 2,096 retrospectively evaluated metastatic spinal cord compression (MSCC) patients. This study aimed to validate the score in a prospective series. METHODS AND MATERIALS: The score included five factors associated with post-RT ambulatory status: tumor type, interval tumor diagnosis to MSCC, visceral metastases, pre-RT motor function, time developing motor deficits. Patients were divided into five groups: 21-28, 29-31, 32-34, 35-37, 38-44 points. In this study, 653 prospectively followed patients were divided into the same groups. Furthermore, the number of prognostic groups was reduced from five to three (21-28, 29-37, 38-44 points). Post-RT ambulatory rates from this series were compared with the retrospective series. Additionally, this series was compared with 104 patients receiving decompressive surgery plus RT (41 laminectomy, 63 laminectomy plus stabilization of vertebrae).
RESULTS: In this study, post-RT ambulatory rates were 10.6% (21-28 points), 43.5% (29-31 points), 71.0% (32-34 points), 89.5% (35-37 points), and 98.5% (38-44 points). Ambulatory rates from the retrospective study were 6.2%, 43.5%, 70.0%, 86.1%, and 98.7%. After regrouping, ambulatory rates were 10.6% (21-28 points), 70.9% (29-37 points), and 98.5% (38-44 points) in this series, and 6.2%, 68.4%, and 98.7% in the retrospective series. Ambulatory rates were 0%, 62.5%, and 90.9% in the laminectomy plus RT group, and 14.3%, 83.9%, and 100% in the laminectomy + stabilization plus RT group.
CONCLUSIONS: Ambulatory rates in the different groups in this study were similar to those in the retrospective study demonstrating the validity of the score. Using only three groups is simpler for clinical routine.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20605351     DOI: 10.1016/j.ijrobp.2010.01.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Onsite versus offsite radiation treatment of malignant spinal cord compression: lessons from a safety net health system.

Authors:  Albert C Chen; Mark D Bonnen; Henry Mok
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

2.  Fractionated external beam radiotherapy of skull base metastases with cranial nerve involvement.

Authors:  L H Dröge; T Hinsche; M Canis; B Alt-Epping; C F Hess; H A Wolff
Journal:  Strahlenther Onkol       Date:  2013-12-22       Impact factor: 3.621

Review 3.  Scoring system for prediction of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiroshi Uei; Masashi Oshima; Yasumitsu Ajiro
Journal:  World J Orthop       Date:  2014-07-18

4.  International survey of the treatment of metastatic spinal cord compression.

Authors:  Samuel Ryu; Ernesto Maranzano; Steven E Schild; Arjun Sahgal; Yoshiya Yamada; Peter Hoskin; Dirk Rades; Anushree Vichare; Carol Hahn; Tanya Holt
Journal:  J Radiosurg SBRT       Date:  2015

Review 5.  Palliative radiotherapy.

Authors:  Katie Spencer; Rhona Parrish; Rachael Barton; Ann Henry
Journal:  BMJ       Date:  2018-03-23

6.  A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression.

Authors:  Dirk Rades; Ahmed Al-Salool; Christian Staackmann; Florian Cremers; Jon Cacicedo; Darejan Lomidze; Barbara Segedin; Blaz Groselj; Natalia Jankarashvili; Antonio J Conde-Moreno; Raquel Ciervide; Charlotte Kristiansen; Steven E Schild
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.